After Eisai Pharmaceuticals set up a wholly owned subsidiary in the country in September 2005, it’s now the turn of the $200-million Nippon Zoki Pharmaceutical to make an India foray.
Mumbai: The Japanese interest in the Indian pharma industry is getting stronger.
After Eisai Pharmaceuticals set up a wholly owned subsidiary in the country in September 2005, it’s now the turn of the $200-million Nippon Zoki Pharmaceutical to make an India foray.
Nippon Zoki has no plans to set up a wholly owned subsidiary, but is interested in signing some outsourcing deals with a few Mumbai-based pharmaceutical companies for Active Pharmaceutical Ingredients (API) and formulations.
The latest entrant from the $65-billion Japanese market is already in the final stages of talks with some companies and a deal could be signed within a couple of months.
Akimoto Michio, general manager, Nippon Zoki Pharmaceutical, told DNA Money,
“We are now discussing with certain pharmaceutical companies, mainly in Mumbai, to import their final formulations as well as APIs. Our first contract will be signed hopefully within the coming months, to be followed by other contracts with other companies. We are seeking APIs, mainly in the segments of anti-pain and anti-allergic.”
Fujisawa Healthcare and Tanabe Seiyaku are the other Japanese companies to have some Indian connection. Both have tied up with Elder Pharma for marketing two anti-hypertensive products in India.
And more are waiting on the wings. Hyoshipara, Takeda, Mitsubishi Pharmaceuticals, Sumitomo, Sankyo, Teisho and Shinogi all have an eye on India. From joint research to product outsourcing to marketing alliances, they have varied interests.
Nippon Zoki is eyeing India as a serious destination for outsourcing APIs and formulations.
“We are looking for bulk drug manufacturing firms having good manufacturing practices (GMP) facilities and better technologies. If we buy out the APIs, the Indian companies will have to file the drug master file (DMF),” Michio said.
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
)
){kind=small}
){kind=small}
)
)
)
)
)
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}